| |
|
SciGen Ltd is a high growth biopharmaceutical company manufacturing and delivering high quality, low cost healthcare products globally. The Company is generating revenues through its portfolio of generic and proprietary drugs. The Company has been listed on the Australian Stock Exchange (ASX: SIE) since 2002.
Register for Updates:
SciGen takes pride in keeping its investors and other interested parties informed of business activities. Click here to register for updates.
Company & Stock Data:
ASX Code: SIE (www.asx.com.au)
Click here to view
6 month chart
|
 |
| Key investment information: |
|
| Market capitalisation: |
A$50.8m |
| Official listing date |
Nov 2002 |
| |
|
| Capital structure: |
|
| Ordinary shares on issue |
552.3m |
| Options (fully diluted) |
51.0m |
| Convertible notes/other |
0 |
| |
|
| Substantial shareholders: |
|
| Bioton S.A. |
90.54% |
| |
|
| Cash position: |
|
| Cash at June 30 2007 |
USD$8.2m |
|
|
